Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health Catalyst (HCAT) EBT (2018 - 2025)

Health Catalyst (HCAT) has disclosed EBT for 8 consecutive years, with -$22.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBT fell 45.96% year-over-year to -$22.2 million, compared with a TTM value of -$106.7 million through Sep 2025, down 34.52%, and an annual FY2024 reading of -$69.2 million, up 41.28% over the prior year.
  • EBT was -$22.2 million for Q3 2025 at Health Catalyst, up from -$40.9 million in the prior quarter.
  • Across five years, EBT topped out at -$13.4 million in Q2 2024 and bottomed at -$49.1 million in Q4 2021.
  • Average EBT over 5 years is -$30.3 million, with a median of -$30.2 million recorded in 2023.
  • The sharpest move saw EBT skyrocketed 58.66% in 2024, then plummeted 204.16% in 2025.
  • Year by year, EBT stood at -$49.1 million in 2021, then increased by 27.31% to -$35.7 million in 2022, then grew by 15.55% to -$30.2 million in 2023, then soared by 33.55% to -$20.0 million in 2024, then dropped by 10.67% to -$22.2 million in 2025.
  • Business Quant data shows EBT for HCAT at -$22.2 million in Q3 2025, -$40.9 million in Q2 2025, and -$23.5 million in Q1 2025.